Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ExcelVite, formerly known as Carotech, is a global leader in the production of palm-based phytonutrients, specifically tocotrienols and mixed-carotenoids. The company operates the world's largest integrated molecular distillation plant, utilizing a patented process to extract high-purity ingredients from non-GMO crude palm oil. Its flagship product, EVNol SupraBio, is a clinically-proven tocotrienol complex featuring a self-emulsifying delivery system for enhanced bioavailability. ExcelVite's research pipeline focuses on the therapeutic potential of tocotrienols in neuroprotection, cardiovascular health, and liver diseases such as non-alcoholic steatohepatitis (NASH). The company's ingredients are widely used in the dietary supplement, functional food, and cosmetic industries worldwide. Headquartered in Malaysia, ExcelVite maintains a strong commitment to sustainable sourcing and holds various international quality certifications, including GMP and ISO.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carotech.